Skip to main content
. 2014 Jun 14;14:441. doi: 10.1186/1471-2407-14-441

Table 2.

Toxicities

 
No. of Patients (%)
 
  Grade 1 Grade 2 Grade 3 Grade 4
Hematologic event
 
 
 
 
Neutropenia
2 (7.4)
3 (11.1)
2 (7.4)
0 (0.0)
Febrile neutropenia
-
-
0 (0.0)
0 (0.0)
Thrombocytopenia
12 (44.4)
1 (3.7)
3 (11.1)
0 (0.0)
Anemia
10 (37.0)
5 (18.5)
2 (7.4)
0 (0.0)
Nonhematologic event
 
 
 
 
Asthenia
7 (25.9)
11 (40.7)
4 (14.8)
0 (0.0)
Nausea/Vomiting
10 (37.0)
6 (22.2)
0 (0.0)
0 (0.0)
Mucitis
3 (11.1)
0 (0.0)
0 (0.0)
0 (0.0)
Diarrhea
6 (22.2)
4 (14.8)
0 (0.0)
0 (0.0)
Sensory neuropathy 10 (37.0) 2 (7.4) 2 (7.4) 0 (0.0)

Toxicities were evaluated according to National Cancer Institute Common Terminology Criteria for Adverse Events (version 3.0).